Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100854
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2005-01-06
Brief Title:
Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International
Organization Data
Organization:
Translational Oncology Research International
Class:
OTHER
Study ID:
CDR0000407580
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Translational Oncology Research International
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |